Australia's CSL is wielding the axe, cutting its workforce by 15% – around 3,000 positions – while announcing plans to spin its vaccines unit into a standalone company. The decision to demerge the CSL ...

Immerse yourself in the world of virtual racing with our roundup of the best sim racing rigs. From entry-level to pro-grade, ...

uniQure and CSL have become the first pharma companies to get regulatory approval for a gene therapy for haemophilia B anywhere in the world, after the FDA cleared their Hemgenix therapy for adults ...

CSL shares have tumbled 35% in 2025, partly attributed to an underwhelming FY 2025 results release and plans to spin off its Seqirus segment. The company's fiscal year 2026 revenue and profit outlook ...

CSL is trading near the bottom of its 52-week range and below its 200-day simple moving average. Price change The price of CSL shares has decreased $17.13 since the market last closed. This is a 4.92% ...

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.

DD is trading near the top of its 52-week range and above its 200-day simple moving average. Price change The price of DD shares has decreased $1.29 since the market last closed. This is a 2.55% drop.

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

1 Day DD -2.16% DJIA -1.07% S&P 500 -1.24% Basic Materials/Resources -4.64% ...